67 related articles for article (PubMed ID: 16137573)
21. Nitric oxide synthase deficiency and the pathophysiology of muscular dystrophy.
Tidball JG; Wehling-Henricks M
J Physiol; 2014 Nov; 592(21):4627-38. PubMed ID: 25194047
[TBL] [Abstract][Full Text] [Related]
22. L-arginine supplementation protects exercise performance and structural integrity of muscle fibers after a single bout of eccentric exercise in rats.
Lomonosova YN; Shenkman BS; Kalamkarov GR; Kostrominova TY; Nemirovskaya TL
PLoS One; 2014; 9(4):e94448. PubMed ID: 24736629
[TBL] [Abstract][Full Text] [Related]
23. Functional muscle ischemia in Duchenne and Becker muscular dystrophy.
Thomas GD
Front Physiol; 2013 Dec; 4():381. PubMed ID: 24391598
[TBL] [Abstract][Full Text] [Related]
24. Sarcospan: a small protein with large potential for Duchenne muscular dystrophy.
Marshall JL; Crosbie-Watson RH
Skelet Muscle; 2013 Jan; 3(1):1. PubMed ID: 23282144
[TBL] [Abstract][Full Text] [Related]
25. Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.
Martin EA; Barresi R; Byrne BJ; Tsimerinov EI; Scott BL; Walker AE; Gurudevan SV; Anene F; Elashoff RM; Thomas GD; Victor RG
Sci Transl Med; 2012 Nov; 4(162):162ra155. PubMed ID: 23197572
[TBL] [Abstract][Full Text] [Related]
26. Treatment with a nitric oxide-donating NSAID alleviates functional muscle ischemia in the mouse model of Duchenne muscular dystrophy.
Thomas GD; Ye J; De Nardi C; Monopoli A; Ongini E; Victor RG
PLoS One; 2012; 7(11):e49350. PubMed ID: 23139842
[TBL] [Abstract][Full Text] [Related]
27. Genetic ablation of arginase 1 in macrophages and neutrophils enhances clearance of an arthritogenic alphavirus.
Stoermer KA; Burrack A; Oko L; Montgomery SA; Borst LB; Gill RG; Morrison TE
J Immunol; 2012 Oct; 189(8):4047-59. PubMed ID: 22972923
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide in myogenesis and therapeutic muscle repair.
De Palma C; Clementi E
Mol Neurobiol; 2012 Dec; 46(3):682-92. PubMed ID: 22821188
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.
Buono R; Vantaggiato C; Pisa V; Azzoni E; Bassi MT; Brunelli S; Sciorati C; Clementi E
Stem Cells; 2012 Feb; 30(2):197-209. PubMed ID: 22084027
[TBL] [Abstract][Full Text] [Related]
30. Drug discovery for Duchenne muscular dystrophy via utrophin promoter activation screening.
Moorwood C; Lozynska O; Suri N; Napper AD; Diamond SL; Khurana TS
PLoS One; 2011; 6(10):e26169. PubMed ID: 22028826
[TBL] [Abstract][Full Text] [Related]
31. Level of muscle regeneration in limb-girdle muscular dystrophy type 2I relates to genotype and clinical severity.
Krag TO; Hauerslev S; Sveen ML; Schwartz M; Vissing J
Skelet Muscle; 2011 Oct; 1(1):31. PubMed ID: 21970816
[TBL] [Abstract][Full Text] [Related]
32. A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy.
Sciorati C; Miglietta D; Buono R; Pisa V; Cattaneo D; Azzoni E; Brunelli S; Clementi E
Pharmacol Res; 2011 Sep; 64(3):210-7. PubMed ID: 21609764
[TBL] [Abstract][Full Text] [Related]
33. Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy.
Peterson JM; Kline W; Canan BD; Ricca DJ; Kaspar B; Delfín DA; DiRienzo K; Clemens PR; Robbins PD; Baldwin AS; Flood P; Kaumaya P; Freitas M; Kornegay JN; Mendell JR; Rafael-Fortney JA; Guttridge DC; Janssen PM
Mol Med; 2011; 17(5-6):508-15. PubMed ID: 21267511
[TBL] [Abstract][Full Text] [Related]
34. Nitrosative stress elicited by nNOSµ delocalization inhibits muscle force in dystrophin-null mice.
Li D; Yue Y; Lai Y; Hakim CH; Duan D
J Pathol; 2011 Jan; 223(1):88-98. PubMed ID: 21125668
[TBL] [Abstract][Full Text] [Related]
35. The Dietary Supplement Protandim Decreases Plasma Osteopontin and Improves Markers of Oxidative Stress in Muscular Dystrophy Mdx Mice.
Qureshi MM; McClure WC; Arevalo NL; Rabon RE; Mohr B; Bose SK; McCord JM; Tseng BS
J Diet Suppl; 2010 Jun; 7(2):159-178. PubMed ID: 20740052
[TBL] [Abstract][Full Text] [Related]
36. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies.
Perronnet C; Vaillend C
J Biomed Biotechnol; 2010; 2010():849426. PubMed ID: 20625423
[TBL] [Abstract][Full Text] [Related]
37. Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.
Sciorati C; Buono R; Azzoni E; Casati S; Ciuffreda P; D'Angelo G; Cattaneo D; Brunelli S; Clementi E
Br J Pharmacol; 2010 Jul; 160(6):1550-60. PubMed ID: 20590643
[TBL] [Abstract][Full Text] [Related]
38. Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.
Guerron AD; Rawat R; Sali A; Spurney CF; Pistilli E; Cha HJ; Pandey GS; Gernapudi R; Francia D; Farajian V; Escolar DM; Bossi L; Becker M; Zerr P; de la Porte S; Gordish-Dressman H; Partridge T; Hoffman EP; Nagaraju K
PLoS One; 2010 Jun; 5(6):e11220. PubMed ID: 20574530
[TBL] [Abstract][Full Text] [Related]
39. Arginine metabolism by macrophages promotes cardiac and muscle fibrosis in mdx muscular dystrophy.
Wehling-Henricks M; Jordan MC; Gotoh T; Grody WW; Roos KP; Tidball JG
PLoS One; 2010 May; 5(5):e10763. PubMed ID: 20505827
[TBL] [Abstract][Full Text] [Related]
40. Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy.
Pertille A; de Carvalho CL; Matsumura CY; Neto HS; Marques MJ
Int J Exp Pathol; 2010 Feb; 91(1):63-71. PubMed ID: 20002835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
